These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 32728212)

  • 1. The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic.
    Kadosh E; Snir-Alkalay I; Venkatachalam A; May S; Lasry A; Elyada E; Zinger A; Shaham M; Vaalani G; Mernberger M; Stiewe T; Pikarsky E; Oren M; Ben-Neriah Y
    Nature; 2020 Oct; 586(7827):133-138. PubMed ID: 32728212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CKIα ablation highlights a critical role for p53 in invasiveness control.
    Elyada E; Pribluda A; Goldstein RE; Morgenstern Y; Brachya G; Cojocaru G; Snir-Alkalay I; Burstain I; Haffner-Krausz R; Jung S; Wiener Z; Alitalo K; Oren M; Pikarsky E; Ben-Neriah Y
    Nature; 2011 Feb; 470(7334):409-13. PubMed ID: 21331045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRAF
    Reischmann N; Andrieux G; Griffin R; Reinheckel T; Boerries M; Brummer T
    Oncogene; 2020 Sep; 39(38):6053-6070. PubMed ID: 32792685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commensal microbes and p53 in cancer progression.
    Celardo I; Melino G; Amelio I
    Biol Direct; 2020 Nov; 15(1):25. PubMed ID: 33213502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing the tumorigenic potential of genetic interactions reconstituted in murine fallopian tube organoids.
    Maru Y; Tanaka N; Tatsumi Y; Nakamura Y; Yao R; Noda T; Itami M; Hippo Y
    J Pathol; 2021 Oct; 255(2):177-189. PubMed ID: 34184756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal cancer progression by mutant p53 through the acquisition of invasiveness associated with complex glandular formation.
    Nakayama M; Sakai E; Echizen K; Yamada Y; Oshima H; Han TS; Ohki R; Fujii S; Ochiai A; Robine S; Voon DC; Tanaka T; Taketo MM; Oshima M
    Oncogene; 2017 Oct; 36(42):5885-5896. PubMed ID: 28628120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of wild-type p53 promotes mutant p53-driven metastasis through acquisition of survival and tumor-initiating properties.
    Nakayama M; Hong CP; Oshima H; Sakai E; Kim SJ; Oshima M
    Nat Commun; 2020 May; 11(1):2333. PubMed ID: 32393735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiome alters functions of mutant p53 to promote tumorigenesis.
    Lau HCH; Yu J
    Signal Transduct Target Ther; 2020 Oct; 5(1):232. PubMed ID: 33037184
    [No Abstract]   [Full Text] [Related]  

  • 9.
    Tian Y; Wang X; Cramer Z; Rhoades J; Estep KN; Ma X; Adams-Tzivelekidis S; Katona BW; Johnson FB; Yu Z; Blanco MA; Lengner CJ; Li N
    Gut; 2023 Nov; 72(12):2294-2306. PubMed ID: 37591698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gain of function in the mouse model of a recurrent mutation p53
    Zhao L; Wang B; Zhao X; Wu X; Zhang Q; Wei C; Shi M; Li Y; Tang W; Zhang J; Yang J; Singh SK; Jia S; Luo Y
    Mol Carcinog; 2018 Feb; 57(2):147-158. PubMed ID: 28949402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phospho-switch controls RNF43-mediated degradation of Wnt receptors to suppress tumorigenesis.
    Tsukiyama T; Zou J; Kim J; Ogamino S; Shino Y; Masuda T; Merenda A; Matsumoto M; Fujioka Y; Hirose T; Terai S; Takahashi H; Ishitani T; Nakayama KI; Ohba Y; Koo BK; Hatakeyama S
    Nat Commun; 2020 Sep; 11(1):4586. PubMed ID: 32934222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gain-of-function mutant p53 promotes the oncogenic potential of head and neck squamous cell carcinoma cells by targeting the transcription factors FOXO3a and FOXM1.
    Tanaka N; Zhao M; Tang L; Patel AA; Xi Q; Van HT; Takahashi H; Osman AA; Zhang J; Wang J; Myers JN; Zhou G
    Oncogene; 2018 Mar; 37(10):1279-1292. PubMed ID: 29269868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbes' Impact on Oncogenic Drivers: Location Matters.
    White MG; Wargo JA
    Mol Cell; 2020 Sep; 79(6):878-880. PubMed ID: 32946762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant p53 oncogenicity: dominant-negative or gain-of-function?
    Stein Y; Aloni-Grinstein R; Rotter V
    Carcinogenesis; 2020 Dec; 41(12):1635-1647. PubMed ID: 33159515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UHRF2 promotes intestinal tumorigenesis through stabilization of TCF4 mediated Wnt/β-catenin signaling.
    Li L; Duan Q; Zeng Z; Zhao J; Lu J; Sun J; Zhang J; Siwko S; Wong J; Shi T; Zhang X; Liu M; Chen J; Li D
    Int J Cancer; 2020 Oct; 147(8):2239-2252. PubMed ID: 32372448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 and its mutants on the slippery road from stemness to carcinogenesis.
    Molchadsky A; Rotter V
    Carcinogenesis; 2017 Apr; 38(4):347-358. PubMed ID: 28334334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM.
    Song H; Hollstein M; Xu Y
    Nat Cell Biol; 2007 May; 9(5):573-80. PubMed ID: 17417627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gain-of-Function Mutant p53: All the Roads Lead to Tumorigenesis.
    Stein Y; Rotter V; Aloni-Grinstein R
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant p53 in colon cancer.
    Nakayama M; Oshima M
    J Mol Cell Biol; 2019 Apr; 11(4):267-276. PubMed ID: 30496442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.